
Proposed Government changes to legislation will require businesses to track and trace all R&D expenditure if they want to continue …

Lilly chief executive John Lechleiter has warned that two key UK initiatives could fall seriously short of encouraging investment in …
The UK pharma industry has responded warmly to government plans to review how best to create optimum conditions for private …

A decision by the UK Government to reform the corporation tax system has been followed by a major job creation …

GlaxoSmithKline has posted a third quarter loss after sales of its troubled diabetes drug Avandia and pandemic influenza products fell. …
GlaxoSmithKline chief executive Andrew Witty has hailed a new UK government ‘blueprint’ to help improve the country’s competitiveness in the …
UK pharma industry association the ABPI has promoted Alison Clough to commercial and communications director. She moves into the new …